TLDR Minoxidil reduces lysine hydroxylase in skin cells.
Minoxidil, a drug used to treat hair loss, was found to specifically decrease the amount of lysine hydroxylase protein in cultured human skin fibroblasts. This decrease is due to a decrease in its synthesis at a pretranslational level, as minoxidil markedly decreases the amount of lysine hydroxylase mRNA. The decrease in the lysine hydroxylase mRNA appeared to be highly specific, as no changes were seen in the amounts of mRNAs for the a- or B-subunits of proline 4-hydroxylase or for y-actin.
63 citations,
September 1987 in “Journal of Biological Chemistry” Minoxidil slows fibroblast growth and collagen production, potentially treating keloids, hypertrophic scars, and connective tissue disorders.
38 citations,
June 2005 in “Matrix Biology” Minoxidil affects collagen-related genes, potentially helping treat fibrosis.
19 citations,
January 1987 in “Dermatology” Minoxidil slows down skin cell growth and may help treat scars and skin conditions.
9 citations,
March 2019 in “Molecular & cellular proteomics” Reductive stress messes up collagen balance and alters cell signaling in human skin cells, which could help treat certain skin diseases.
January 1989 in “Clinical and Experimental Dermatology” The symposium concluded that hair growth involves complex processes, including the hair follicle life cycle, the role of the dermal papilla, hair strength, pigmentation, and the impact of diseases and treatments like minoxidil on hair and skin.
20 citations,
January 1994 in “Archives of Biochemistry and Biophysics” Minoxidil needs specific structure to block lysyl hydroxylase; exploring alternatives may keep benefits without this effect.